Literature DB >> 21235709

Progressive multifocal leukoencephalopathy (PML) after transplantation.

Christina Nguyen, Ron Shapiro.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21235709      PMCID: PMC4048955          DOI: 10.1111/j.1399-3046.2010.01464.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


× No keyword cloud information.
  6 in total

1.  Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies?

Authors:  Kenneth L Tyler
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

Review 2.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  David Shitrit; Nirit Lev; Ariella Bar-Gil-Shitrit; Mordechai R Kramer
Journal:  Transpl Int       Date:  2004-12-23       Impact factor: 3.782

Review 3.  Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation.

Authors:  Anna Bellizzi; Valentina Barucca; Daniela Fioriti; Maria T Colosimo; Monica Mischitelli; Elena Anzivino; Fernanda Chiarini; Valeria Pietropaolo
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

4.  Cytokine production by activated T cells in common variable immunodeficiency.

Authors:  N Rezaei; A Aghamohammadi; M Nourizadeh; G A Kardar; Z Pourpak; A Zare; R C Read
Journal:  J Investig Allergol Clin Immunol       Date:  2010       Impact factor: 4.333

5.  Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.

Authors:  Robert T Neff; Frank P Hurst; Edward M Falta; Erin M Bohen; Krista L Lentine; Vikas R Dharnidharka; Lawrence Y Agodoa; Rahul M Jindal; Christina M Yuan; Kevin C Abbott
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

Review 6.  Primary antibody deficiency syndromes.

Authors:  P Wood
Journal:  Ann Clin Biochem       Date:  2009-01-16       Impact factor: 2.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.